Mukka Proteins Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹508.9 Cr (+108% YoY), EBITDA ₹50.1 Cr (9.9% margin), PAT ₹17.7 Cr (3.5%). Targets ₹3,000+ Cr revenue by FY30.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Q2 FY27 consolidated revenue ₹508.9 Cr (+108% YoY), EBITDA ₹50.1 Cr (9.9% margin), PAT ₹17.7 Cr (3.5%). Targets ₹3,000+ Cr revenue by FY30.
Mukka Proteins reported strong Q1 FY27 results, driven by favorable fishmeal pricing and improved realizations as it transitions into an integrated animal protein and sustainability platform.
Mukka Proteins reported strong FY26 performance with 44% revenue growth reaching ₹1,449.5 Cr. The company is pivoting from a fishmeal producer to an integrated animal protein and sustainability platform.